Cited by 916Sepsis Diagnosis and TreatmentHemodynamic Monitoring and TherapyTrauma, Hemostasis, Coagulopathy, Resuscitation

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Angiotensin II for the Treatment of Vasodilatory Shock

Open access

Khanna, Ashish, English, Shane W., Wang, Xueyuan S., Ham, Kealy, Tumlin, James, Szerlip, Harold, Busse, Laurence W., Altaweel, Laith, Albertson, Timothy E., Mackey, Caleb, McCurdy, Michael T., Boldt, David W., Chock, Stefan, Young, Paul J., Krell, Kenneth, Wunderink, Richard G., Ostermann, Marlies, Murugan, Raghavan, Gong, Michelle N., Panwar, Rakshit, Hästbacka, Johanna, Favory, Raphael, Venkatesh, Balasubramanian, Thompson, B. Taylor, Bellomo, Rinaldo, Jensen, Jeffrey, Kroll, Stew, Chawla, Lakhmir S., Tidmarsh, George F., Deane, Adam M.·2017·New England Journal of Medicine

DOI 10.1056/nejmoa1704154

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: Vasodilatory shock that does not respond to high-dose vasopressors is associated with high mortality. We investigated the effectiveness of angiotensin II for the treatment of patients with this condition. METHODS: We randomly assigned patients with vasodilatory shock who were receiving more than 0.2 μg of norepinephrine per kilogram of body weight per minute or the equivalent dose of another vasopressor to receive infusions of either angiotensin II or placebo. The primary end point was a response with respect to mean arterial pressure at hour 3 after the start of infusion, with response defined as an increase from baseline of at least 10 mm Hg or an increase to at least 75 mm Hg, without an increase in the dose of background vasopressors. RESULTS: A total of 344 patients were assigned to one of the two regimens; 321 received a study intervention (163 received angiotensin II, and 158 received placebo) and were included in the analysis. The primary end point was reached by more patients in the angiotensin II group (114 of 163 patients, 69.9%) than in the placebo group (37 of 158 patients, 23.4%) (odds ratio, 7.95; 95% confidence interval [CI], 4.76 to 13.3; P<0.001). At 48 hours, the mean improvement in the cardiovascular Sequential Organ Failure Assessment (SOFA) score (scores range from 0 to 4, with higher scores indicating more severe dysfunction) was greater in the angiotensin II group than in the placebo group (-1.75 vs. -1.28, P=0.01). Serious adverse events were reported in 60.7% of the patients in the angiotensin II group and in 67.1% in the placebo group. Death by day 28 occurred in 75 of 163 patients (46%) in the angiotensin II group and in 85 of 158 patients (54%) in the placebo group (hazard ratio, 0.78; 95% CI, 0.57 to 1.07; P=0.12). CONCLUSIONS: Angiotensin II effectively increased blood pressure in patients with vasodilatory shock that did not respond to high doses of conventional vasopressors. (Funded by La Jolla Pharmaceutical Company; ATHOS-3 ClinicalTrials.gov number, NCT02338843 .).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejmoa1704154

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

APACHE II
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1985) · Critical Care Medicine · doi:10.1097/00003246-198510000-00009 · Cited by 15,518
APACHE II-A Severity of Disease Classification System
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00028 · Cited by 13,379
The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure: On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine (see contributors to the project in the appendix)
Vincent, J. L., Moreno, R., Takala, J., Willatts, S., De Mendonça, A., Bruining, H., Reinhart, C. K., Suter, P. M., & Thijs, L. G. (1996) · Intensive Care Medicine · doi:10.1007/bf01709751 · Cited by 11,674
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2769-8 · Cited by 7,371
Comparison of Dopamine and Norepinephrine in the Treatment of Shock
De Backer, D., Biston, P., Devriendt, J., Madl, C., Chochrad, D., Aldecoa, C., Brasseur, A., Defrance, P., Gottignies, P., & Vincent, J.-L. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907118 · Cited by 1,940
Epidemiology of severe sepsis
Mayr, F., Yende, S. P., & Angus, D. C. (2013) · Virulence · doi:10.4161/viru.27372 · Cited by 1,298
Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: Effect on survival in patients with septic shock*
López, A., Lorente, J. A., Steingrub, J. S., Bakker, J., McLuckie, A., Willatts, S. M., Brockway, M., Anzueto, A., Holzapfel, L., Breen, D. P., et al. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000105581.01815.c6 · Cited by 917
Effect of Heart Rate Control With Esmolol on Hemodynamic and Clinical Outcomes in Patients With Septic Shock
Morelli, A., Ertmer, C., Westphal, M., Rehberg, S. W., Kampmeier, T., Ligges, S., Orecchioni, A., D’Egidio, A., D''Ippoliti, F., Raffone, C., et al. (2013) · JAMA · doi:10.1001/jama.2013.278477 · Cited by 739
History about the discovery of the renin-angiotensin system.
Basso, N., & Terragno, N. (2001) · HYPERTENSION · doi:10.1161/hy1201.101214 · Cited by 236
Survival After Shock Requiring High-Dose Vasopressor Therapy
Brown, S. M., Lanspa, M. J., Jones, J. P., Kuttler, K. G., Li, Y., Carlson, R., Miller, R. R., Hirshberg, E. L., Grissom, C. K., & Morris, A. H. (2013) · CHEST Journal · doi:10.1378/chest.12-1106 · Cited by 211

Flagged first, then by citations

Show all 24 references

Research works printed but not linked: 2

Chawla LS, 2017, Crit Care Resusc, 19, 43
Bassi E, 2013, Crit Care Res Pract, 2013, 654708

Sorted by citations

Items 701–800 of 916

Catecholamine Refractory Vasodilatory Shock: Can Therapy Become Patient Specific?
Ortoleva, J. P., French, A. L., & Dalia, A. A. (2020) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2020.02.014 · Cited by 1
Why the Use of Angiotensin II May be a Fatal Mistake in COVID-19
Ferreira, J., McManus, J., Jankowski, C. A., & Searcy, R. J. (2020) · Shock · doi:10.1097/shk.0000000000001577 · Cited by 1
Silencing of CRT relieves Ang II-Induced injury of HUVECs with insulin resistance
Deng, B., Feng, J., Wang, L., & Chen, X. (2020) · Journal of Receptors and Signal Transduction · doi:10.1080/10799893.2020.1808677 · Cited by 1
Severe hand sanitiser (isopropanol) toxicity managed with continuous venovenous haemodiafiltration and angiotensin II
Chieng, S., Malouf, S., Costa‐Pinto, R., Bellomo, R., Gerostamoulos, D., & Wong, A. (2021) · Clinical Toxicology · doi:10.1080/15563650.2021.1910289 · Cited by 1
Self-citation
Preservation of Renal Function
Privratsky, J. R., Cherry, A. D., Andrew, B. Y., & Stafford‐Smith, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-56724-4.00017-4 · Cited by 1
Clinical Update on Vasopressors and Titration Strategies
Ragoonanan, D., & Friedman, L. (2021) · AACN Advanced Critical Care · doi:10.4037/aacnacc2021106 · Cited by 1
The Renin-Angiotensin System in COVID19
Mallick, U. (2022) · Springer eBooks · doi:10.1007/978-3-030-90065-6_8 · Cited by 1
Latest Evidence
Sartini, C., Maimeri, N., & Belletti, A. (2021) · Springer eBooks · doi:10.1007/978-3-030-71917-3_23 · Cited by 1
Care of the critically ill patient
Cairns, T., & Faulds, M. (2018) · Surgery (Oxford) · doi:10.1016/j.mpsur.2018.01.002 · Cited by 1
Rethinking Vasopressor Education: The Need to Avoid Teaching the Bare Minimum
McCurdy, M. T., & Busse, L. W. (2023) · ATS Scholar · doi:10.34197/ats-scholar.2023-0030le · Cited by 1
Self-citation
Selepressin for Patients With Septic Shock
Rehberg, S. W., Morelli, A., & Jansen, G. (2020) · JAMA · doi:10.1001/jama.2019.20848 · Cited by 1
Selepressin for Patients With Septic Shock—Reply
Angus, D. C., Laterre, P., Lewis, R. J., & for the SEPSIS-ACT Investigators (2020) · JAMA · doi:10.1001/jama.2019.20863 · Cited by 1
Contribution of Cardiothoracic and Abdominal Transplant Anesthesiologists: Leading the Way for the Full Spectrum of Patients in Midst of COVID-19 Pandemic
Abrams, B. A., Kertai, M. D., & Weitzel, N. S. (2020) · Seminars in Cardiothoracic and Vascular Anesthesia · doi:10.1177/1089253220946176 · Cited by 1
Commentary: Angiotensin II for vasoplegia: A desperate measure for desperate times
Balsam, L. B. (2020) · JTCVS Techniques · doi:10.1016/j.xjtc.2020.08.043 · Cited by 1
Commentary: Renin Angiotensin System Inhibitors and Cardiac Surgery–“More Than Meets the Eye”
Beaver, T. M., & Ejaz, A. A. (2021) · Seminars in Thoracic and Cardiovascular Surgery · doi:10.1053/j.semtcvs.2021.01.041 · Cited by 1
Angiotensinogen Takes Some of the Spotlight From Angiotensin II in the Cardiohepatic Axis
Jones, S. P. (2021) · Circulation Research · doi:10.1161/circresaha.121.319784 · Cited by 1
Methanol - some developments in a versatile synfuel
Othmer, D. F. (1983) · Am. Soc. Mech. Eng., (Pap.); (United States) · Cited by 1
Cardiogenic Shock
Rodríguez-Yago, M. A., Blanch, L. L., & Albaiceta, G. M. (2026) · New England Journal of Medicine · doi:10.1056/nejmc2601118 · Cited by 1
Clinical trials testing early multimodal vasopressor therapy require a dose ceiling, not a dose floor
Wieruszewski, P. M., & Khanna, A. K. (2026) · Critical Care · doi:10.1186/s13054-026-06378-y · Cited by 1
Self-citation
Circulation and circulatory support in the critically ill
Pinsky, M. R. (2020) · doi:10.1093/med/9780198746690.003.0389
Management of Sepsis and Septic Shock
Sagana, R. L., & Hyzy, R. C. (2017) · Springer eBooks · doi:10.1007/978-3-319-43341-7_53
More quality for trials in critically ill patients
Redaelli, M. B., Cabrini, L., Landoni, G., & Bellomo, R. (2017) · Journal of Critical Care · doi:10.1016/j.jcrc.2017.07.048
Self-citation
Sepsis in 2017: after three decades of change, where are we now?
Jain, S. (2017)
Angiotensin II increases blood pressure in patients with refractory vasodilatory shock
Landoni, G., & Belletti, A. (2018) · BMJ Evidence-Based Medicine · doi:10.1136/ebmed-2017-110870
Advanced Cardiovascular Support in Refractory Shock
Shetty, R. M., & Udupa, A. N. (2018) · Indian Journal of Respiratory Care · doi:10.4103/ijrc.ijrc_2_17
Drugs acting on the cerebral and peripheral circulations
Smetana, K. S., & May, C. C. (2019) · Side effects of drugs annual · doi:10.1016/bs.seda.2019.08.003
Shock and Vasopressors: State-of-the-Art Update
Kouch, M., & Dellinger, R. P. (2018) · Springer eBooks · doi:10.1007/978-3-319-94424-1_11
Case report: Septic shock, addressing aspects of the organism and the resultant effects on the vasculature
Capatos, G. (2018) · The Egyptian Journal of Critical Care Medicine · doi:10.1016/j.ejccm.2018.12.012
Vasoplegia in the Postoperative Period After Cardiac Transplantation
Chan, J. L., & Esmailian, F. (2019) · Difficult decisions in surgery: an evidence-based approach · doi:10.1007/978-3-030-04146-5_23
Modern Critical Care Endocrinology and Its Impact on Critical Care Medicine
Bellomo, R. (2019) · Critical Care Clinics · doi:10.1016/j.ccc.2019.01.001
Self-citation
The Year in Cardiothoracic Critical Care: Selected Highlights From 2017
Gutsche, J. T., Ghadimi, K., Augoustides, J. G., Laudański, K., Evans, A. S., Weiner, M. M., Raiten, J. M., Gordon, E. K. B., Milewski, R. K., Horák, J., et al. (2018) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2018.04.023
ICU Management of the Cardiac Patient
Patel, V., & Nizamuddin, J. (2019) · Oxford University Press eBooks · doi:10.1093/med/9780190884512.003.0036
One approach to circulation and blood flow in the critical care unit
Pena-Hernandez, C., & NUGENT, K. M. (2019) · World Journal of Critical Care Medicine · doi:10.5492/wjccm.v8.i4.36
Acute Kidney Injury in Critically Ill Children: Epidemiology, Risk Factors, and Outcomes
Alobaidi, R. (2019) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3-cd1f-nx16
Just a Little Off the Top, Please*
Busse, L. W. (2019) · Critical Care Medicine · doi:10.1097/ccm.0000000000004050
Self-citation
Postoperative Critical Care Management Considerations
Nilsson, K. F., & Axelsson, B. (2019) · Hot topics in acute care surgery and trauma · doi:10.1007/978-3-030-25341-7_16
Establishing a Research Program in the ICU
Busse, L. W., Hall, A. J., & Sevransky, J. (2020) · Springer eBooks · doi:10.1007/978-3-030-33808-4_18
Self-citation
Current sepsis research
Seckel, M. A. (2020) · Nursing Critical Care · doi:10.1097/01.ccn.0000654796.79252.dc
What's New in Shock, April 2020?
Cirino, J. A., Delano, M. J., & Napolitano, L. M. (2020) · Shock · doi:10.1097/shk.0000000000001508
Update of acute kidney injury
Doi, K. (2019) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.108.1212
Case Scenario for Fluid Therapy in Septic Shock
Khanna, A. K., Font, M. D., & Mathur, P. (2020) · Springer eBooks · doi:10.1007/978-3-030-48374-6_22
Self-citation
Has evidence-based medicine changed the practice of critical care?
Levinson, A., & Levy, M. M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-64068-8.00010-9
Kidney and the Heart in Multiorgan System Failure
Katz, N. M. (2020) · Springer eBooks · doi:10.1007/978-3-030-57460-4_19
The Effect of Angiotensin II Infusion on Markers of Organ Function in Invasively Ventilated COVID-19 PatientsPreprint
Zangrillo, A., Colombo, S., Scandroglio, A. M., Fominskiy, E. V., Pieri, M., Calabró, M. G., Beccaria, P. F., Pasculli, N., Guzzo, F., Calvi, M. R., et al. (2020) · doi:10.21203/rs.3.rs-52230/v1
Self-citation
Commentary: Is angiotensin II a game changer for vasoplegia after cardiac surgery, or is the jury still out?
Chatterjee, S. (2021) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2021.03.074
Angiotensin II in the Treatment of Distributive Shock, an Old Theory Revitalized
Leach, J. D., & Curran, D. P. (2020) · JMU Scholoraly Commons (James Madison University)
Vasopressoren: Physiologie, Pharmakologie und klinischer Einsatz
Keller, M., & Magunia, H. (2021) · AINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie · doi:10.1055/a-1214-4472
Sepsis and Septic Shock
Burton, J., & Singer, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-56724-4.00038-1
Vasopressor Support for Patients with Cardiopulmonary Failure
Backer, D. D., & Foulon, P. (2021) · Springer eBooks · doi:10.1007/978-3-030-73387-2_49
Non-adrenergic Vasopressors in Septic Shock: Overview and Update
Antonucci, E., Giovini, M., & Sakr, Y. L. (2021) · Annual update in intensive care and emergency medicine · doi:10.1007/978-3-030-73231-8_7
Contribuições científicas da disciplina de Emergências Clínicas da Faculdade de Medicina da Universidade de São Paulo para o enfrentamento à Pandemia de COVID-19
de Alencar, J. C. G. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2021.tde-11112021-101425
What’s to Be Found in the Wisdom of the Crowd?
Carr, J. R., Peltan, I. D., & Lanspa, M. J. (2021) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202105-574ed
Angiotensin II
Baker, D. E., & Levien, T. L. (2018) · Hospital Pharmacy · doi:10.1177/0018578718778224
Evaluating biomarkers of post-cardiac surgery vasodilatory shock: Research caveats be concurrently marked
Magoon, R., & Jose, J. (2022) · Journal of Critical Care · doi:10.1016/j.jcrc.2022.154027
Vasopressin: The Impact of Predatory Patents on a Captive ICU Marketplace*
Peterson, L.-K. N., & Devlin, J. W. (2022) · Critical Care Medicine · doi:10.1097/ccm.0000000000005348
Vasopressors in Resuscitation
Ghosh, S. (2022) · Springer eBooks · doi:10.1007/978-981-19-0500-1_8
Sepsis and the Inflammatory Response to Injury
Shnaydman, I., & Bronstein, M. E. (2022) · Wiley eBooks · doi:10.1002/9781119756781.ch5
Infection, sepsis, and multiorgan dysfunction syndrome
Vincent, J. (2021) · Oxford University Press eBooks · doi:10.1093/med/9780198849346.003.0071
The authors reply
Bellomo, R., Kroll, S., Chawla, L. S., & Tidmarsh, G. F. (2019) · Critical Care Medicine · doi:10.1097/ccm.0000000000003601
Self-citation
Sepsis
Deisenberg, M., & Knirsch, W. (2019) · Elsevier eBooks · doi:10.1016/b978-3-437-21982-5.00013-x
3 Impact of Acute Surgical Illness on Critical Care Decisions Pre- and Postoperatively
(2020) · Thieme eBooks · doi:10.1055/b-0040-178599
Shock
Kenaan, M., & Eagle, K. A. (2018) · doi:10.1093/med/9780190862800.003.0013
Drugs Acting on the Cerebral and Peripheral Circulations
Smetana, K. S., Noel, Z. R., & Ray, S. D. (2018) · Side effects of drugs annual · doi:10.1016/bs.seda.2018.06.004
Pharmacological Interventions in Acute Kidney Injury
Chopra, T., Balogun, R. A., & Okusa, M. D. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-52978-5.00048-3
In Reply
Russell, J. A. (2017) · Anesthesiology · doi:10.1097/aln.0000000000001957
Management of Sepsis and Septic Shock
Sagana, R. L., & Hyzy, R. C. (2020) · Springer eBooks · doi:10.1007/978-3-030-26710-0_60
Neurocritical Care Pharmacology
McConnell, D. (2022) · Cambridge University Press eBooks · doi:10.1017/9781108907682.006
II. Diagnosis and Therapeutics in Acute Kidney Injury
Doi, K. (2021) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.110.905
Study to Explore the Association of the Renin-Angiotensin System and Right Ventricular Function in Mechanically Ventilated Patients
Dessap, A. M., Hanrott, K., Powley, W. M., Fowler, A. V., Bayliffe, A. I., Bagate, F., Hall, D. A., Lazaar, A. L., Budd, D. C., & Vieillard‐Baron, A. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11154362
Crosstalk Between Abnormal Electrical Activity and Angiotensin II Cell Signaling in the Hyperglycemic Mammalian Heart
Turan, B. (2023) · Advances in biochemistry in health and disease · doi:10.1007/978-3-031-14952-8_3
Clinical Management of Endotoxemia: Vasoactive and Cardiostimulant Drugs
Cocci, G., d’Errico, R., Villa, G., & Romagnoli, S. (2023) · Springer eBooks · doi:10.1007/978-3-031-18591-5_9
Septic Shock
Bakker, J. (2023) · Lessons from the ICU · doi:10.1007/978-3-031-17572-5_6
Metabolomics Approach in Differentiating RAS Responses in ARDS and SAR-CoV-2
Lu, A., Zhou, E., Ahluwalia, K., Patel, K., Naik, A. A., Asante, I., & Louie, S. G. (2023) · Advances in biochemistry in health and disease · doi:10.1007/978-3-031-23621-1_6
Anesthesiology for Trauma Medicine: Roles, Medications, Airway Management, and Multidisciplinary Team Coordination
Reese, V. C., Bauerle, W. B., Allsbrook, A. P., Hwang, J. M., & Hehar, P. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.110101
Precision Medicine in Septic Shock
Chiscano‐Camón, L., Ruiz‐Rodríguez, J. C., & Ferrer, R. (2023) · Annual update in intensive care and emergency medicine · doi:10.1007/978-3-031-23005-9_5
Critically ill children with septic shock: time to rediscover renin?
Guzzo, I., & Paglialonga, F. (2023) · Pediatric Nephrology · doi:10.1007/s00467-023-05985-z
Cardiogenic Shock
Takeda, K., Witer, L. J., & Takayama, H. (2023) · Wiley eBooks · doi:10.1002/9781119633884.ch40
Reply to: Rethinking Vasopressor Education: The Need to Avoid Teaching the Bare Minimum
Manson, D. K., Dzierba, A. L., Seitz, K. M., & Brodie, D. (2023) · ATS Scholar · doi:10.34197/ats-scholar.2023-0049le
Vasopressor cocktails (we all have drug shortages)
Greenwood, J. C. (2023) · Oxford University Press eBooks · doi:10.1093/med/9780190082581.003.0016
Hemodynamic Cardiovascular Indices to Predict the Response to Angiotensin-II in Septic Shock
Carrara, M., Garcia, B., Herpain, A., & Ferrario, M. (2024) · World Congress on Medical Physics and Biomedical Engineering, September 7 - 12, 2009, Munich, Germany · doi:10.1007/978-3-031-49068-2_35
Estrategia integral de reanimación del paciente con sepsis y shock séptico
del Río-Carbajo, L., Olmo, J. N.-D., Fernández‐Ugidos, P., & Vidal, P. (2022) · Medicina Intensiva (English Edition) · doi:10.1016/j.medine.2022.02.025
Use of Inotropes and vasopressors in Septic Shock: When, Why, and How?
Qura’an, B., Omar, H. B., Al-Qaqa, O., Abu‐Jeyyab, M., Hattab, M. G., & Ruzieh, M. (2024) · JAP Academy Journal · doi:10.58877/japaj.v2i1.115
Additional file 1 of Rapid implementation of an emergency on-site CKRT dialysate production system during the COVID-19 pandemic
Teixeira, J. P., Saa, L., Kaucher, K. A., Villanueva, R. D., Shieh, M., Baca, C. R., Harmon, B., Owen, Z. J., Majalca, I. M., Schmidt, D. W., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24012931
Vasopressin Use During Liver Transplantation Is Not Associated with Severe Acute Kidney Injury: A Propensity Score Adjusted Regression Analysis v1Preprint
Antonucci, E., Bokoch, M. P., & Kothari, R. P. (2024) · doi:10.17504/protocols.io.6qpvr8dd2lmk/v1
Sepsis-Associated Acute Kidney Injury
Saraiva, I. E. B., Zaidi, S. A., Prenna, S., Marengo, M., Piscia, R., Colombatto, A., Cantaluppi, V., & Gómez, H. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95488-4.00088-7
Terminologie et dose de noradrénaline : une clarification s’impose
Bounes, F. V., Goyer, I., Guerci, P., Léone, M., & Mongardon, N. (2024) · Le Praticien en Anesthésie Réanimation · doi:10.1016/j.pratan.2024.05.002
Effects of extracorporeal blood purification therapies on organ dysfunction in critically ill patients
Kanjo, A. (2023) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.11578
Is “Less be More” Still a Valid Concept in Intensive Care? A Review of Critical Care Randomized Clinical Trials from the New England Journal of Medicine
Kapadia, F. N., Sharma, R., & Bharadwaj, S. (2024) · Indian Journal of Critical Care Medicine · doi:10.5005/jp-journals-10071-24717
Non-Adrenergic Vasoconstrictors
Lee, A., & Schulman, N. J. (2024) · doi:10.1093/med/9780197584569.003.0289
Proposal for the use of angiotensin II in distributive shock after extracorporeal circulation – position paper of the Section of Intensive Care Medicine and the Section of Cardiothoracic Anaesthesiology of the Polish Society of Anaesthesiology and Intensive Therapy
Krzych, Ł. J., Nadziakiewicz, P., & Kucewicz-Czech, E. M. (2024) · Polish Journal of Cardio-Thoracic Surgery · doi:10.5114/kitp.2024.141146
Terminologie et dose de noradrénaline : parlons-nous le même langage ?
Mongardon, N., Goyer, I., Bounes, F. V., Guerci, P., & Léone, M. (2024) · Anesthésie & Réanimation · doi:10.1016/j.anrea.2024.04.001
Kinetics of Renin Concentrations in Infants Undergoing Congenital Cardiac Surgery
Kim, M. E., Gist, K. M., Brandewie, K. L., Zang, H., Lehenbauer, D. G., Winlaw, D. S., Morales, D. L. S., Alten, J. A., Goldstein, S. L., & Cooper, D. S. (2024) · Journal of Intensive Care Medicine · doi:10.1177/08850666241268655
Diagnosis and Definition of Cardiogenic Shock
Lim, H. S. (2024) · Springer eBooks · doi:10.1007/978-3-031-64740-6_12
Assessing organ function in the critically ill patient
Vincent, J. (2024) · Journal of Translational Critical Care Medicine · doi:10.1097/jtccm-d-24-00038
Đặc điểm lâm sàng và các yếu tố liên quan tới sốc nhiễm khuẩn kháng trị tại khoa Hồi sức tích cực
Nguyễn, T. T., Lê, H. T. B., Trần, T. L., & Đỗ, T. T. (2024) · Y HOC TP HO CHI MINH · doi:10.32895/hcjm.m.2024.04.14
Angiotensin II administration in severe thrombocytopenia and chronic venous thrombosis: A case report
Brajković, A. V., Markota, A., Bielen, L., Vujević, A., Rora, M., & Radonić, R. (2024) · World Journal of Critical Care Medicine · doi:10.5492/wjccm.v13.i4.96755
Year 2024 in review - Cardiovascular issues in intensive care and perioperative medicine
Smékalová, O., Klimovič, A., Kletečka, J., Zatloukal, J., & Beneš, J. (2024) · Anesteziologie a intenzivní medicína · doi:10.36290/aim.2024.054
A Pilot, Single-Blinded, Randomized Crossover Trial of Cramp Reduction with Angiotensin II in Maintenance Patients on Hemodialysis (the CRAMP-HD Study)
Phongphithakchai, A., Bellomo, R., Mount, P. F., Bach, C.-A. T., Gurry, G., Liu, W. J., Maeda, A., Pattamin, N., Hikasa, Y., Spano, S., et al. (2025) · American Journal of Nephrology · doi:10.1159/000543280
Self-citation
Teripressin Is Used in Septic Shock Still Norepinephrine?
刘, 澳. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.152314
Cardiovascular drugs
Carter, A., Singer, M., & Webb, A. R. (2025) · Oxford University Press eBooks · doi:10.1093/med/9780199688876.003.0015

Authors: Khanna, A., English, S. W., Wang, X. S., Ham, K., Tumlin, J., Szerlip, H., Busse, L. W., Altaweel, L., Albertson, T. E., Mackey, C., McCurdy, M. T., Boldt, D. W., Chock, S., Young, P. J., Krell, K., Wunderink, R. G., Ostermann, M., Murugan, R., Gong, M. N., Panwar, R., Hästbacka, J., Favory, R., Venkatesh, B., Thompson, B. T., Bellomo, R., Jensen, J., Kroll, S., Chawla, L. S., Tidmarsh, G. F., & Deane, A. M.
Affiliations: Cleveland Clinic (US)
Regions Hospital (US)
Inova Health System (US)
Albert Einstein College of Medicine (US)
University of Maryland, Baltimore (US)
Northwestern University (US)
ORCID: Khanna, Ashish
English, Shane W.
Ham, Kealy
Szerlip, Harold
Busse, Laurence W.
Albertson, Timothy E.
McCurdy, Michael T.
Young, Paul J.
Wunderink, Richard G.
Ostermann, Marlies
Murugan, Raghavan
Gong, Michelle N.
Panwar, Rakshit
Hästbacka, Johanna
Venkatesh, Balasubramanian
Thompson, B. Taylor
Bellomo, Rinaldo
Chawla, Lakhmir S.
Deane, Adam M.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2017-08-03
Volume: 377
Issue: 5
Pages: 419-430
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmoa1704154
OpenAlex: W2614578436
Cited by: 916
References: 24
Citations by year: 2026: 100 · 2025: 103 · 2024: 121 · 2023: 103 · 2022: 90 · 2021: 95 · 2020: 123 · 2019: 80 · 2018: 75 · 2017: 25
FWCI: 64.87
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
ePrints Soton (University of Southampton) (submittedVersion)
Figshare (submittedVersion)
Työväentutkimus Vuosikirja (submittedVersion)
Queen Mary Research Online (Queen Mary University of London) (submittedVersion)
NOVA (University of Newcastle Australia) (submittedVersion)
Funders: Bristol-Myers Squibb
GlaxoSmithKline
La Jolla Pharmaceutical Company
Alexion Pharmaceuticals
Regeneron Pharmaceuticals
Genentech
Topics: Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
Health Sciences › Medicine › Surgery › Hemodynamic Monitoring and Therapy
Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Trauma, Hemostasis, Coagulopathy, Resuscitation
Keywords: angiotensin II, vasodilatory shock, septic shock, vasopressors, norepinephrine, mean arterial pressure, SOFA score, mortality, blood pressure response, adverse events, sepsis treatment, vasopressor-refractory shock, fluid resuscitation, vasopressor dose reduction, organ dysfunction, 28-day mortality
MeSH terms: Aged, Angiotensin II, Blood Pressure, Catecholamines, Double-Blind Method, Drug Therapy, Combination, Female, Humans, Hypotension, Male, Middle Aged, Shock, Vasoconstrictor Agents, Organ Dysfunction Scores

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Angiotensin II for the Treatment of Vasodilatory Shock

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks